Udemy to Present at Needham’s 2024 Annual Growth Conference
SAN FRANCISCO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Udemy (Nasdaq: UDMY), a leading online skills marketplace and learning platform, today […]
Omega Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the […]
Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the […]
PLBY Group to Participate in the 2024 ICR Conference
LOS ANGELES, Jan. 02, 2024 (GLOBE NEWSWIRE) — PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading […]
Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8:00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER Trials
WALTHAM, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on […]
Biomea Fusion to Present at the 42nd Annual J.P. Morgan Healthcare Conference
REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated […]
Titan Machinery Inc. to Participate in the 2024 ICR Conference
WEST FARGO, N.D., Jan. 02, 2024 (GLOBE NEWSWIRE) — Titan Machinery Inc. (Nasdaq: TITN), a leading network of full-service agricultural […]
EverQuote to Participate at the 26th Annual Needham Growth Conference
CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace, today announced that […]
Cardlytics Appoints Two New Members to its Board of Directors
ATLANTA, Jan. 02, 2024 (GLOBE NEWSWIRE) — Cardlytics, Inc. (NASDAQ: CDLX), an advertising platform in banks’ digital channels, is excited […]
Y-mAbs Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 02, 2024 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical […]
